These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7224 related articles for article (PubMed ID: 1841713)
1. An autologous T cell clone overcomes intra-melanoma heterogeneity for susceptibility to cell-mediated lysis by using multiple lytic mechanisms: in vitro and in vivo analysis. Mazzocchi A; Rodolfo M; Parmiani G; Anichini A Melanoma Res; 1991; 1(3):169-76. PubMed ID: 1841713 [TBL] [Abstract][Full Text] [Related]
2. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxic activity and lymphokine production of T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ cytotoxic T lymphocyte (CTL) clones recognizing HLA-A2 and HLA-A2 mutants. Recognition of TCR-gamma delta+ CTL clones is affected by mutations at positions 152 and 156. Spits H; Paliard X; Engelhard VH; de Vries JE J Immunol; 1990 Jun; 144(11):4156-62. PubMed ID: 2111341 [TBL] [Abstract][Full Text] [Related]
4. Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma. Nisticò P; Mortarini R; De Monte LB; Mazzocchi A; Mariani M; Malavasi F; Parmiani G; Natali PG; Anichini A J Clin Invest; 1992 Sep; 90(3):1093-9. PubMed ID: 1387883 [TBL] [Abstract][Full Text] [Related]
5. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL. Lancki DW; Kaper BP; Fitch FW J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047 [TBL] [Abstract][Full Text] [Related]
6. T lymphocytes can mediate lysis of autologous melanoma cells by multiple mechanisms: evidence with a single T cell clone. Mazzocchi A; Anichini A; Castelli C; Sensi M; Poli F; Russo C; Parmiani G Cancer Immunol Immunother; 1990; 32(1):13-21. PubMed ID: 2149669 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction. Anichini A; Mazzocchi A; Fossati G; Parmiani G J Immunol; 1989 May; 142(10):3692-701. PubMed ID: 2469723 [TBL] [Abstract][Full Text] [Related]
8. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity. de Vries JE; Spits H J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458 [TBL] [Abstract][Full Text] [Related]
9. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level. Sensi M; Orosz CG; Bach FH J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778 [TBL] [Abstract][Full Text] [Related]
10. Dual recognition of a human cytotoxic T-cell clone for melanoma antigens. Kubo H; Abe J; Obata F; Nakajima H; Tsunoda M; Ogawa A; Nakayama S; Beck Y; Kohsaka T; Darrow TL; Abdel-Wahab Z; Saida T; Takiguchi M Cancer Res; 1996 May; 56(10):2368-74. PubMed ID: 8625313 [TBL] [Abstract][Full Text] [Related]
11. Recognition and lysis of human melanoma by a CD3+, CD4+, CD8- T-cell clone restricted by HLA-A2. Darrow TL; Abdel-Wahab Z; Quinn-Allen MA; Seigler HF Cell Immunol; 1996 Aug; 172(1):52-9. PubMed ID: 8806806 [TBL] [Abstract][Full Text] [Related]
12. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies. van de Griend RJ; Giphart MJ; Van Krimpen BA; Bolhuis RL J Immunol; 1984 Sep; 133(3):1222-9. PubMed ID: 6205072 [TBL] [Abstract][Full Text] [Related]
13. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response. Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798 [TBL] [Abstract][Full Text] [Related]
14. 707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma. Takahashi T; Irie RF; Nishinaka Y; Hoon DS Clin Cancer Res; 1997 Aug; 3(8):1363-70. PubMed ID: 9815820 [TBL] [Abstract][Full Text] [Related]
15. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells. Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076 [TBL] [Abstract][Full Text] [Related]
16. Immunoselection of a human melanoma resistant to specific lysis by autologous tumor-infiltrating lymphocytes. Possible mechanisms for immunotherapeutic failures. Topalian SL; Kasid A; Rosenberg SA J Immunol; 1990 Jun; 144(11):4487-95. PubMed ID: 2160503 [TBL] [Abstract][Full Text] [Related]
17. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens. Darrow TL; Slingluff CL; Seigler HF J Immunol; 1989 May; 142(9):3329-35. PubMed ID: 2785141 [TBL] [Abstract][Full Text] [Related]
18. Lysis of human keratinocytes by allogeneic HLA class I-specific cytotoxic T cells. Keratinocyte ICAM-1 (CD54) and T cell LFA-1 (CD11a/CD18) mediate enhanced lysis of IFN-gamma-treated keratinocytes. Symington FW; Santos EB J Immunol; 1991 Apr; 146(7):2169-75. PubMed ID: 1672345 [TBL] [Abstract][Full Text] [Related]
19. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function. Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156 [TBL] [Abstract][Full Text] [Related]
20. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes. Voogt PJ; Falkenburg JH; Fibbe WE; Veenhof WF; Hamilton M; Van Krimpen BA; Bolhuis RL J Immunol; 1989 Mar; 142(5):1774-80. PubMed ID: 2521886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]